Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2014, January) Reactions Weekly Vol. 1484 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2014 (January)Volume1484
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13309008Long-form Identifiermindat:1:5:13309008:8
GUID0
Full Reference(2014, January) Reactions Weekly Vol. 1484 (1) Springer Science and Business Media LLC
Plain Text(2014, January) Reactions Weekly Vol. 1484 (1) Springer Science and Business Media LLC
In(2014) Reactions Weekly Vol. 1484. Springer Science and Business Media LLC

Contains

(2014) Varespladib trial terminated, increased MI risk. Reactions Weekly, 1484 (1) 1 doi:10.1007/s40278-014-8217-5
(2014) Methylphenidate: risk of priapism. Reactions Weekly, 1484 (1) 2 doi:10.1007/s40278-014-8218-4
(2014) Nationwide recall of products due to lack of sterility assurance. Reactions Weekly, 1484 (1) 2 doi:10.1007/s40278-014-8219-3
(2014) FDA announces proposal to regulate antibacterial soap claims. Reactions Weekly, 1484 (1) 2 doi:10.1007/s40278-014-8220-x
(2014) Linoladiol N/HN remain available in the EU, advises CHMP. Reactions Weekly, 1484 (1) 2 doi:10.1007/s40278-014-8221-9
(2014) Ponatinib to be marketed again following new safety measures. Reactions Weekly, 1484 (1) 3 doi:10.1007/s40278-014-8222-8
(2014) Adverse events during dual RAAS blockade in diabetic nephropathy. Reactions Weekly, 1484 (1) 3 doi:10.1007/s40278-014-8223-7
(2014) New evidence of CV risk with testosterone therapy. Reactions Weekly, 1484 (1) 3 doi:10.1007/s40278-014-8224-6
(2014) No link between fluoroquinolones and retinal detachment. Reactions Weekly, 1484 (1) 4 doi:10.1007/s40278-014-8225-5
(2014) Allopurinol. Reactions Weekly, 1484 (1) 5 doi:10.1007/s40278-014-8226-4
(2014) Adalimumab. Reactions Weekly, 1484 (1) 5 doi:10.1007/s40278-014-8227-3
(2014) Adefovir dipivoxil. Reactions Weekly, 1484 (1) 5 doi:10.1007/s40278-014-8228-2
(2014) Albendazole. Reactions Weekly, 1484 (1) 5 doi:10.1007/s40278-014-8229-1
(2014) Amiodarone. Reactions Weekly, 1484 (1) 6 doi:10.1007/s40278-014-8230-8
(2014) Alteplase. Reactions Weekly, 1484 (1) 6 doi:10.1007/s40278-014-8231-7
(2014) Amlodipine/hydrochlorothiazide/lisinopril overdose. Reactions Weekly, 1484 (1) 6 doi:10.1007/s40278-014-8232-6
(2014) Amoxicillin/clavulanic acid. Reactions Weekly, 1484 (1) 6 doi:10.1007/s40278-014-8233-5
(2014) Antidepressants/fentanyl/ondansetron. Reactions Weekly, 1484 (1) 7 doi:10.1007/s40278-014-8234-4
(2014) Anagliptin. Reactions Weekly, 1484 (1) 7 doi:10.1007/s40278-014-8235-3
(2014) Antihypertensives/nitroglycerin. Reactions Weekly, 1484 (1) 7 doi:10.1007/s40278-014-8236-2
(2014) Antibacterials/antituberculars. Reactions Weekly, 1484 (1) 7 doi:10.1007/s40278-014-8237-1
(2014) Atorvastatin. Reactions Weekly, 1484 (1) 8 doi:10.1007/s40278-014-8238-0
(2014) Aspirin/caffeine/ephedrine. Reactions Weekly, 1484 (1) 8 doi:10.1007/s40278-014-8239-z
(2014) Azathioprine. Reactions Weekly, 1484 (1) 8 doi:10.1007/s40278-014-8240-6
(2014) Aspirin. Reactions Weekly, 1484 (1) 8 doi:10.1007/s40278-014-8241-5
(2014) Aspirin/clopidogrel. Reactions Weekly, 1484 (1) 8 doi:10.1007/s40278-014-8242-4
(2014) Brimonidine/timolol. Reactions Weekly, 1484 (1) 9 doi:10.1007/s40278-014-8243-3
(2014) Azathioprine. Reactions Weekly, 1484 (1) 9 doi:10.1007/s40278-014-8244-2
(2014) Bevacizumab. Reactions Weekly, 1484 (1) 9 doi:10.1007/s40278-014-8245-1
(2014) Caffeine overdose. Reactions Weekly, 1484 (1) 10 doi:10.1007/s40278-014-8246-0
(2014) Buprenorphine. Reactions Weekly, 1484 (1) 10 doi:10.1007/s40278-014-8247-z
(2014) Bupivacaine/fentanyl/morphine. Reactions Weekly, 1484 (1) 10 doi:10.1007/s40278-014-8248-y
(2014) Bupivacaine/lidocaine. Reactions Weekly, 1484 (1) 10 doi:10.1007/s40278-014-8249-x
(2014) Capecitabine. Reactions Weekly, 1484 (1) 11 doi:10.1007/s40278-014-8250-4
(2014) Ciclosporin. Reactions Weekly, 1484 (1) 11 doi:10.1007/s40278-014-8251-3
(2014) Carvedilol/sotalol. Reactions Weekly, 1484 (1) 11 doi:10.1007/s40278-014-8252-2
(2014) Cetuximab/paclitaxel. Reactions Weekly, 1484 (1) 11 doi:10.1007/s40278-014-8253-1
(2014) Clozapine. Reactions Weekly, 1484 (1) 12 doi:10.1007/s40278-014-8254-0
(2014) Clarithromycin/colchicine interaction. Reactions Weekly, 1484 (1) 12 doi:10.1007/s40278-014-8255-z
(2014) Cimetidine/fluoxetine/ranolazine. Reactions Weekly, 1484 (1) 12 doi:10.1007/s40278-014-8256-y
(2014) Ciclosporin. Reactions Weekly, 1484 (1) 12 doi:10.1007/s40278-014-8257-x
(2014) Clindamycin. Reactions Weekly, 1484 (1) 12 doi:10.1007/s40278-014-8258-9
(2014) Clozapine. Reactions Weekly, 1484 (1) 13 doi:10.1007/s40278-014-8259-8
(2014) Crizotinib. Reactions Weekly, 1484 (1) 13 doi:10.1007/s40278-014-8260-2
(2014) Cyclophosphamide/doxorubicin/paclitaxel. Reactions Weekly, 1484 (1) 13 doi:10.1007/s40278-014-8261-1
(2014) Decitabine. Reactions Weekly, 1484 (1) 14 doi:10.1007/s40278-014-8262-0
(2014) Dalteparin sodium/heparin. Reactions Weekly, 1484 (1) 14 doi:10.1007/s40278-014-8263-z
(2014) Dapsone. Reactions Weekly, 1484 (1) 14 doi:10.1007/s40278-014-8264-y
(2014) Dabigatran etexilate. Reactions Weekly, 1484 (1) 14 doi:10.1007/s40278-014-8265-x
(2014) Diclofenac. Reactions Weekly, 1484 (1) 15 doi:10.1007/s40278-014-8266-9
(2014) Diltiazem. Reactions Weekly, 1484 (1) 15 doi:10.1007/s40278-014-8267-8
(2014) Desmopressin. Reactions Weekly, 1484 (1) 15 doi:10.1007/s40278-014-8268-7
(2014) Diltiazem. Reactions Weekly, 1484 (1) 15 doi:10.1007/s40278-014-8269-6
(2014) Domperidone overdose. Reactions Weekly, 1484 (1) 16 doi:10.1007/s40278-014-8270-0
(2014) Docetaxel. Reactions Weekly, 1484 (1) 16 doi:10.1007/s40278-014-8271-z
(2014) Doxycycline. Reactions Weekly, 1484 (1) 16 doi:10.1007/s40278-014-8272-y
(2014) Donepezil. Reactions Weekly, 1484 (1) 16 doi:10.1007/s40278-014-8273-x
(2014) Dosulepin/sertraline. Reactions Weekly, 1484 (1) 16 doi:10.1007/s40278-014-8274-9
(2014) Efavirenz. Reactions Weekly, 1484 (1) 17 doi:10.1007/s40278-014-8275-8
(2014) Eperisone/various other drugs overdose. Reactions Weekly, 1484 (1) 17 doi:10.1007/s40278-014-8276-7
(2014) Enoxaparin sodium. Reactions Weekly, 1484 (1) 17 doi:10.1007/s40278-014-8277-6
(2014) Enoxaparin sodium. Reactions Weekly, 1484 (1) 17 doi:10.1007/s40278-014-8278-5
(2014) Ferric chloride. Reactions Weekly, 1484 (1) 18 doi:10.1007/s40278-014-8279-4
(2014) Etanercept. Reactions Weekly, 1484 (1) 18 doi:10.1007/s40278-014-8280-y
(2014) Ethinylestradiol/drospirenone/norelgestromin. Reactions Weekly, 1484 (1) 18 doi:10.1007/s40278-014-8281-x
(2014) Etanercept. Reactions Weekly, 1484 (1) 18 doi:10.1007/s40278-014-8282-9
(2014) Gemcitabine/paclitaxel. Reactions Weekly, 1484 (1) 19 doi:10.1007/s40278-014-8283-8
(2014) Furazolidone/levofloxacin. Reactions Weekly, 1484 (1) 19 doi:10.1007/s40278-014-8284-7
(2014) Fluindione/miconazole interaction. Reactions Weekly, 1484 (1) 19 doi:10.1007/s40278-014-8285-6
(2014) Fluoxetine. Reactions Weekly, 1484 (1) 19 doi:10.1007/s40278-014-8286-5
(2014) Imatinib. Reactions Weekly, 1484 (1) 20 doi:10.1007/s40278-014-8287-4
(2014) Imatinib. Reactions Weekly, 1484 (1) 20 doi:10.1007/s40278-014-8288-3
(2014) Haloperidol. Reactions Weekly, 1484 (1) 20 doi:10.1007/s40278-014-8289-2
(2014) Infliximab. Reactions Weekly, 1484 (1) 20 doi:10.1007/s40278-014-8290-9
(2014) Imatinib. Reactions Weekly, 1484 (1) 20 doi:10.1007/s40278-014-8291-8
(2014) Lamotrigine/sodium valproate. Reactions Weekly, 1484 (1) 21 doi:10.1007/s40278-014-8292-7
(2014) Isotretinoin. Reactions Weekly, 1484 (1) 21 doi:10.1007/s40278-014-8293-6
(2014) Lenalidomide. Reactions Weekly, 1484 (1) 21 doi:10.1007/s40278-014-8294-5
(2014) Ioxaglate sodium. Reactions Weekly, 1484 (1) 21 doi:10.1007/s40278-014-8295-4
(2014) Ipilimumab/vemurafenib. Reactions Weekly, 1484 (1) 21 doi:10.1007/s40278-014-8296-3
(2014) Levamisole. Reactions Weekly, 1484 (1) 22 doi:10.1007/s40278-014-8297-2
(2014) Lorazepam withdrawal. Reactions Weekly, 1484 (1) 22 doi:10.1007/s40278-014-8298-1
(2014) Lithium/methotrexate. Reactions Weekly, 1484 (1) 22 doi:10.1007/s40278-014-8299-0
(2014) Methotrexate/trifolium pratense interaction. Reactions Weekly, 1484 (1) 23 doi:10.1007/s40278-014-8300-y
(2014) Mercaptopurine. Reactions Weekly, 1484 (1) 23 doi:10.1007/s40278-014-8301-x
(2014) Methotrexate. Reactions Weekly, 1484 (1) 23 doi:10.1007/s40278-014-8302-9
(2014) Methadone/naltrexone. Reactions Weekly, 1484 (1) 23 doi:10.1007/s40278-014-8303-8
(2014) Moxifloxacin. Reactions Weekly, 1484 (1) 24 doi:10.1007/s40278-014-8304-7
(2014) Natalizumab withdrawal. Reactions Weekly, 1484 (1) 24 doi:10.1007/s40278-014-8305-6
(2014) Miltefosine. Reactions Weekly, 1484 (1) 24 doi:10.1007/s40278-014-8306-5
(2014) Methylprednisolone. Reactions Weekly, 1484 (1) 24 doi:10.1007/s40278-014-8307-4
(2014) Methylprednisolone. Reactions Weekly, 1484 (1) 24 doi:10.1007/s40278-014-8308-3
(2014) Oxaliplatin. Reactions Weekly, 1484 (1) 25 doi:10.1007/s40278-014-8309-2
(2014) Oxybuprocaine. Reactions Weekly, 1484 (1) 25 doi:10.1007/s40278-014-8310-9
(2014) Paclitaxel. Reactions Weekly, 1484 (1) 25 doi:10.1007/s40278-014-8311-8
(2014) Olmesartan medoxomil. Reactions Weekly, 1484 (1) 25 doi:10.1007/s40278-014-8312-7
(2014) Paclitaxel. Reactions Weekly, 1484 (1) 26 doi:10.1007/s40278-014-8313-6
(2014) Peginterferon-α-2b/ribavirin/telaprevir. Reactions Weekly, 1484 (1) 26 doi:10.1007/s40278-014-8314-5
(2014) Peginterferon-α-2b/ribavirin/telaprevir. Reactions Weekly, 1484 (1) 26 doi:10.1007/s40278-014-8315-4
(2014) Piperacillin/tazobactam. Reactions Weekly, 1484 (1) 27 doi:10.1007/s40278-014-8316-3
(2014) Phenobarbital overdose. Reactions Weekly, 1484 (1) 27 doi:10.1007/s40278-014-8317-2
(2014) Pentazocine. Reactions Weekly, 1484 (1) 27 doi:10.1007/s40278-014-8318-1
(2014) Perampanel. Reactions Weekly, 1484 (1) 27 doi:10.1007/s40278-014-8319-0
(2014) Piperazine overdose. Reactions Weekly, 1484 (1) 28 doi:10.1007/s40278-014-8320-7
(2014) Pramipexole. Reactions Weekly, 1484 (1) 28 doi:10.1007/s40278-014-8321-6
(2014) Prednisone/prednisolone/methylprednisolone. Reactions Weekly, 1484 (1) 28 doi:10.1007/s40278-014-8322-5
(2014) Prednisolone. Reactions Weekly, 1484 (1) 28 doi:10.1007/s40278-014-8323-4
(2014) Pregabalin. Reactions Weekly, 1484 (1) 29 doi:10.1007/s40278-014-8324-3
(2014) Ribavirin. Reactions Weekly, 1484 (1) 29 doi:10.1007/s40278-014-8325-2
(2014) Quetiapine. Reactions Weekly, 1484 (1) 29 doi:10.1007/s40278-014-8326-1
(2014) Quinine overdose. Reactions Weekly, 1484 (1) 29 doi:10.1007/s40278-014-8327-0
(2014) Ritonavir/triamcinolone interaction. Reactions Weekly, 1484 (1) 30 doi:10.1007/s40278-014-8328-z
(2014) Risperidone/sodium valproate. Reactions Weekly, 1484 (1) 30 doi:10.1007/s40278-014-8329-y
(2014) Ritonavir/triamcinolone interaction. Reactions Weekly, 1484 (1) 30 doi:10.1007/s40278-014-8330-5
(2014) Rituximab. Reactions Weekly, 1484 (1) 30 doi:10.1007/s40278-014-8331-4
(2014) Rituximab. Reactions Weekly, 1484 (1) 31 doi:10.1007/s40278-014-8332-3
(2014) Sorafenib. Reactions Weekly, 1484 (1) 31 doi:10.1007/s40278-014-8333-2
(2014) Silver nitrate. Reactions Weekly, 1484 (1) 31 doi:10.1007/s40278-014-8334-1
(2014) Sodium phosphate. Reactions Weekly, 1484 (1) 31 doi:10.1007/s40278-014-8335-0
(2014) Vemurafenib. Reactions Weekly, 1484 (1) 32 doi:10.1007/s40278-014-8336-z
(2014) Triamcinolone. Reactions Weekly, 1484 (1) 32 doi:10.1007/s40278-014-8337-y
(2014) Tacrolimus. Reactions Weekly, 1484 (1) 32 doi:10.1007/s40278-014-8338-x
(2014) Tranexamic acid. Reactions Weekly, 1484 (1) 32 doi:10.1007/s40278-014-8339-9
(2014) Vemurafenib. Reactions Weekly, 1484 (1) 33 doi:10.1007/s40278-014-8340-3
(2014) Ziconotide. Reactions Weekly, 1484 (1) 33 doi:10.1007/s40278-014-8341-2

See Also

These are possibly similar items as determined by title/reference text matching only.

(2014, January) Reactions Weekly Vol. 1483 (1) Springer Science and Business Media LLC
(2014, January) Reactions Weekly Vol. 1485 (1) Springer Science and Business Media LLC
(2022, January) Reactions Weekly Vol. 1891 (1) Springer Science and Business Media LLC
(2022, January) Reactions Weekly Vol. 1889 (1) Springer Science and Business Media LLC
(2022, January) Reactions Weekly Vol. 1887 (1) Springer Science and Business Media LLC
(2022, January) Reactions Weekly Vol. 1888 (1) Springer Science and Business Media LLC
(2022, January) Reactions Weekly Vol. 1890 (1) Springer Science and Business Media LLC
(2017, January) Reactions Weekly Vol. 1633 (1) Springer Science and Business Media LLC
(2017, January) Reactions Weekly Vol. 1634 (1) Springer Science and Business Media LLC
(2017, January) Reactions Weekly Vol. 1635 (1) Springer Science and Business Media LLC
(2017, January) Reactions Weekly Vol. 1636 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 16, 2025 19:48:12
Go to top of page